The University of Glasgow announced that Innovate UK has awarded a university spinout, Acu-Flow, £1 million for development of the company's Nebu-Flow surface acoustic wave nebulizer technology. The University said that its researchers will work with Acu-Flow and the NIHR Devices for Dignity Med-tech Cooperative to have a working nebulizer ready for manufacturing … [Read more...] about Innovate UK awards £1 million grant to Acu-Flow for development of Nebu-Flow technology
Products and Services
Aptar Pharma acquires rights to Pharmaxis’ Orbital DPI
Aptar Pharma announced that it has acquired worldwide rights to Pharmaxis’ high payload Orbital dry powder inhaler. In August 2021, the company said that it had acquired an option to purchase the rights to the Orbital DPI and that it had 12 months to decide whether or not to exercise that option. The Orbital inhaler can handle total doses up to 400 mg and was … [Read more...] about Aptar Pharma acquires rights to Pharmaxis’ Orbital DPI
FDA to provide funding for study to validate Inhalation Sciences’ DissolvIt lung simulation model for dissolution testing of inhaled drugs
According to Inhalation Sciences (ISAB), the FDA will provide up to $500,000 over two years to fund a study intended to validate ISAB's DissolvIt in vitro lung simulation model for dissolution testing of inhaled drugs. The company said that the agency's National Center for Toxicological Research has approved the research proposal, and the study is expected to begin … [Read more...] about FDA to provide funding for study to validate Inhalation Sciences’ DissolvIt lung simulation model for dissolution testing of inhaled drugs
Iconovo gets grant from Gates Foundation for development of nasal DPI
DPI developer Iconovo announced that it has received a $883,800 grant from the Bill & Melinda Gates Foundation for development of a nasal inhaler based on the company's ICOone single dose device. In March 2021, Iconovo announced that it was developing a nasal version of the ICOone inhaler for use with an ISR COVID-19 vaccine and later said that it had received an … [Read more...] about Iconovo gets grant from Gates Foundation for development of nasal DPI
Adherium announces 510(k) clearance for Hailie sensor for use with Ellipta DPIs and new distribution deal
Hailie inhaler monitoring system maker Adherium announced that the FDA has cleared the company's new version of the Hailie sensor for use with Ellipta dry powder inhalers. Adherium submitted the 510(k) application to the FDA in March 2022. The company said that the new clearance means that Hailie is now eligible for reimbursement on 18 of the top 20 branded inhalers … [Read more...] about Adherium announces 510(k) clearance for Hailie sensor for use with Ellipta DPIs and new distribution deal
Recipharm to develop two inhalation formulations for Transpire Bio
Florida-based startup Transpire Bio announced that it has signed an agreement with Recipharm for development of two inhaled candidates, TRB-1 and TRB-2, for the treatment of asthma and COPD. The company says that the two generic MDIs are "intended for advanced markets." Transpire CEO Xian-Ming Zeng said, "Our mission is to improve access to important, life-saving … [Read more...] about Recipharm to develop two inhalation formulations for Transpire Bio
VisionHealth says Boehringer Ingelheim to cooperate on distribution of the Kata inhaler training app in Germany
German digital health company VisionHealth has announced that it will "cooperate on distribution of inhalation platform Kata" with Boehringer Ingelheim in Germany. The Kata app uses artificial intelligence and augmented reality technology in conjunction with the patient's smartphone camera to provide interactive inhaler use coaching. The company says that the app can … [Read more...] about VisionHealth says Boehringer Ingelheim to cooperate on distribution of the Kata inhaler training app in Germany
TFF Pharmaceuticals expands with new R&D facility
TFF Pharmaceuticals announced that it has leased a new 3,500+ square foot R&D facility in Austin, Texas, USA, that will house additional lab space, as well as equipment for the production of preclinical supplies, significantly expanding the company's capabilities. TFF also said that it will continue its relationship with the University of Texas at Austin, where … [Read more...] about TFF Pharmaceuticals expands with new R&D facility
DFE launches Lactohale 400 anhydrous inhalation grade lactose
DFE Pharma has announced the launch of a new product in its range of Lactohale inhalation grade lactose products; Lactohale 400 milled anhydrous lactose is described as a grade for formulations "where a relatively good flow with some cohesiveness is required." According to the company, the median particle size of Lactohale 400 is 100μm, and DFE Pharma will work with … [Read more...] about DFE launches Lactohale 400 anhydrous inhalation grade lactose
H&T Presspart opens low-GWP MDI filling facility
Device maker H&T Presspart has announced the opening of a new laboratory scale facility at its Blackburn, UK Inhalation Product Technology Centre (IPTC) for filling metered dose inhalers with lower global warming potential (GWP) propellants, including both HFA 152a and HFO 1234ze. According to the company, which offers product development services and … [Read more...] about H&T Presspart opens low-GWP MDI filling facility